BR102018010523A2 - peptídeo, composição farmacêutica compreendendo o mesmo e uso - Google Patents

peptídeo, composição farmacêutica compreendendo o mesmo e uso Download PDF

Info

Publication number
BR102018010523A2
BR102018010523A2 BR102018010523A BR102018010523A BR102018010523A2 BR 102018010523 A2 BR102018010523 A2 BR 102018010523A2 BR 102018010523 A BR102018010523 A BR 102018010523A BR 102018010523 A BR102018010523 A BR 102018010523A BR 102018010523 A2 BR102018010523 A2 BR 102018010523A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
peptide
same
insulin
emerging
Prior art date
Application number
BR102018010523A
Other languages
English (en)
Inventor
Suavinho Emer
Cesar Gozzo Fabio
Pariona Llanos Ricardo
Original Assignee
Univ Estadual Campinas Unicamp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Estadual Campinas Unicamp filed Critical Univ Estadual Campinas Unicamp
Priority to BR102018010523A priority Critical patent/BR102018010523A2/pt
Priority to PCT/BR2019/000023 priority patent/WO2019222821A1/pt
Publication of BR102018010523A2 publication Critical patent/BR102018010523A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

a presente invenção descreve um peptídeo análogo da insulina compreendendo a fórmula: aa1-tv- aa2-t- aa3 o qual apresenta a capacidade de reduzir os níveis de glicose no sangue. adicionalmente, são objetos da invenção uma composição farmacêutica contendo o referido peptídeo, bem como o seu uso para preparar a referida composição farmacêutica para esta finalidade, surgindo como uma alternativa terapêutica promissora à administração da insulina.
BR102018010523A 2018-05-23 2018-05-23 peptídeo, composição farmacêutica compreendendo o mesmo e uso BR102018010523A2 (pt)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BR102018010523A BR102018010523A2 (pt) 2018-05-23 2018-05-23 peptídeo, composição farmacêutica compreendendo o mesmo e uso
PCT/BR2019/000023 WO2019222821A1 (pt) 2018-05-23 2019-05-22 Peptídeo, composição farmacêutica compreendendo o mesmo e uso

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR102018010523A BR102018010523A2 (pt) 2018-05-23 2018-05-23 peptídeo, composição farmacêutica compreendendo o mesmo e uso

Publications (1)

Publication Number Publication Date
BR102018010523A2 true BR102018010523A2 (pt) 2020-04-28

Family

ID=68616326

Family Applications (1)

Application Number Title Priority Date Filing Date
BR102018010523A BR102018010523A2 (pt) 2018-05-23 2018-05-23 peptídeo, composição farmacêutica compreendendo o mesmo e uso

Country Status (2)

Country Link
BR (1) BR102018010523A2 (pt)
WO (1) WO2019222821A1 (pt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7873477B1 (en) * 2001-08-21 2011-01-18 Codexis Mayflower Holdings, Llc Method and system using systematically varied data libraries
DE10225144A1 (de) * 2002-05-29 2003-12-18 Immatics Biotechnologies Gmbh An MHC-Moleküle bindende Tumor-assoziierte Peptide
AU2006321027A1 (en) * 2005-11-29 2007-06-07 Denator Aktiebolag Method for determining the quality of a biological sample
EP2867662B1 (en) * 2012-06-27 2021-01-06 Siscapa Assay Technologies, Inc. Multipurpose mass spectrometric assay panels for peptides
CA2903718A1 (en) * 2013-03-13 2014-10-02 Cour Pharmaceuticals Development Co., Inc. Immune-modifying particles for the treatment of inflammation

Also Published As

Publication number Publication date
WO2019222821A1 (pt) 2019-11-28

Similar Documents

Publication Publication Date Title
BR112016016290A2 (pt) Composições farmacêuticas de insulina de ação rápida, conjunto de infusão, sistema de conjunto de infusão e usos de análogos monoméricos ou diméricos de insulina
CL2019001586A1 (es) Insulina que contiene composiciones farmacéuticas.
BR112016029848A2 (pt) proteínas de fusão mic-1 e utilizações das mesmas
AR116605A1 (es) Compuestos bifuncionales que comprenden péptidos de insulina y péptidos de egf(a)
CO2021005226A2 (es) Nuevos compuestos antihelmínticos
AR112353A1 (es) Compuesto de insulina acilada
BR112012022223A2 (pt) formulações de proteína concentrada e usos das mesmas
BR112012024379A2 (pt) "peptídeos glucagon, seu uso, bem como composição farmacêutica"
BR112016017193A2 (pt) Derivados de insulina, seus usos, e composição farmacêutica
AR108021A1 (es) Conjugados de anticuerpo-principio activo (adcs) de inhibidores de ksp con anticuerpos anti-b7h3
AR106364A1 (es) Derivados de insulina y sus usos médicos
BR112015019412A8 (pt) inibidores de bace1, seus usos, e composição farmacêutica
CO2020001242A2 (es) Dihidrooxadiazinonas
BR112014021653A2 (pt) Formulação tópica, método para tratamento de feridas e método para fabricar uma formulação tópica
BR112016001544A8 (pt) composições farmacêuticas para a administração intraocular que compreende um agente antibacteriano e um agente anti-inflamatório
BR112021018506A2 (pt) Terapia de combinação para tratamento do câncer
AR120717A1 (es) Análogos de insulina y usos de los mismos
UY38228A (es) Compuestos de triazolopirimidina y su uso en el tratamiento del cáncer
BR112017010602A2 (pt) análogos de ureia ligados em ponte substituídos como moduladores de sirtuína
BR112017001093A2 (pt) formulação aquosa compreendendo paracetamol e ibuprofeno
PE20210123A1 (es) Compuesto de anillo de metillactama y uso farmaceutico del mismo
CL2020000310A1 (es) Análogos de insulina acilados novedosos y usos de estos.
BR102018010523A2 (pt) peptídeo, composição farmacêutica compreendendo o mesmo e uso
BR112017022390A2 (pt) composição farmacêutica
BR112015013223A2 (pt) composição farmacêutica

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: UNIVERSIDADE ESTADUAL DE CAMPINAS - UNICAMP (BR/SP) ; UNIVERSIDADE DE SAO PAULO - USP (BR/SP)